cd25 pe Search Results


95
Miltenyi Biotec mab against human cd25
Mab Against Human Cd25, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mab against human cd25/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
mab against human cd25 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Miltenyi Biotec anti human cd25 pe conjugated mab
Representative phenotypic analysis of <t>CD25</t> and FoxP3 expression in CD4+ T cells of PBMC compared with LNMC. (A) Freshly isolated PBMC and LNMC were stained for CD3, CD4, CD25 and intracellular FoxP3. CD25 and FoxP3 expression was analyzed in the CD3+CD4+ population. (A) CD25+ Treg cells in PBMC and LNMC were quantified as FoxP3+ and CD25hi (MFI ≥70) as indicated in the box in the upper right quadrant. (B) Representative example of CD25+hi expression on purified CD4+ T cell subsets used in functional assays. (C) Representative example of FoxP3 expression intensity (MFI) on CD25+ CD4+ T cells in LN and PB.
Anti Human Cd25 Pe Conjugated Mab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd25 pe conjugated mab/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
anti human cd25 pe conjugated mab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Miltenyi Biotec pe conjugated anti cd25 7d4
Splenocytes from DEREG mice were incubated in the absence or presence of the indicated concentrations of NAD + before staining with fluorochrome-conjugated mAbs directed against CD4 and CD25 (mAb PC61 or mAb <t>7D4).</t> Gating was performed on CD4 + cells. (a) Representative dot plots of cells incubated in the absence or presence of 12 μM NAD + . (b) Percentages of CD4 + GFP + cells staining with anti-CD25 mAbs plotted as a function of the concentration of added NAD + . Results are representative of two independent experiments.
Pe Conjugated Anti Cd25 7d4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe conjugated anti cd25 7d4/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
pe conjugated anti cd25 7d4 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Cytek Biosciences pe cy7 anti human cd25 antibody
Splenocytes from DEREG mice were incubated in the absence or presence of the indicated concentrations of NAD + before staining with fluorochrome-conjugated mAbs directed against CD4 and CD25 (mAb PC61 or mAb <t>7D4).</t> Gating was performed on CD4 + cells. (a) Representative dot plots of cells incubated in the absence or presence of 12 μM NAD + . (b) Percentages of CD4 + GFP + cells staining with anti-CD25 mAbs plotted as a function of the concentration of added NAD + . Results are representative of two independent experiments.
Pe Cy7 Anti Human Cd25 Antibody, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe cy7 anti human cd25 antibody/product/Cytek Biosciences
Average 93 stars, based on 1 article reviews
pe cy7 anti human cd25 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd25 pe vio770
Splenocytes from DEREG mice were incubated in the absence or presence of the indicated concentrations of NAD + before staining with fluorochrome-conjugated mAbs directed against CD4 and CD25 (mAb PC61 or mAb <t>7D4).</t> Gating was performed on CD4 + cells. (a) Representative dot plots of cells incubated in the absence or presence of 12 μM NAD + . (b) Percentages of CD4 + GFP + cells staining with anti-CD25 mAbs plotted as a function of the concentration of added NAD + . Results are representative of two independent experiments.
Cd25 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd25 pe vio770/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd25 pe vio770 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Cytek Biosciences anti mouse cd25 pe
ERO1A induces T cell dysfunction in response to aPD-1 treatment (A) t-distributed stochastic neighbor embedding (t-SNE) visualization of major cell clusters, colored by cell subtype. Tumors were collected after two rounds of aPD-1 treatment and processed for scRNA-seq (n = 5 mice/group). CAFs, cancer-associated fibroblasts. DCs, dendritic cells. NK, natural killer. (B) t-SNE map of major cell types in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (C) t-SNE map indicating the macrophage clusters based on the scRNA-seq data. Colored by cell subtype. (D) t-SNE map showing the sample origins of macrophages in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (E) t-SNE map depicting the M1 and M2 macrophage signatures based on the scRNA-seq data. (F) Uniform manifold approximation and projection (UMAP) plot showing the RNA velocity of CD8 + T cell subsets. RNA velocities were visualized on the UMAP of Mki67 + Tex, <t>Il2ra</t> + Texp, Tnfrsf9 + Texp, Gzmf + Tem, Ifng + Tm, Ifit1 + Tcm, and CD28 + Tm using Gaussian smoothing on a regular grid. (G and H) Diffusion map of CD8 + T cell clusters shows a resting-to-activated trajectory. The pseudotime expression changes in Lag3 , Pdcd1 , Havcr2 , and Gzmb in CD8 + T cells (G). Pseudotime trajectory of CD8 + T cell subsets in MC-38 Ero1a WT and Ero1a KO tumors (H). Colored by cell subtype. (I and J) Projection of effective CD8 + T cells (I) and proliferative CD8 + T cells (J) based on cell activation, degranulation, and proliferation levels in MC-38 Ero1a WT and Ero1a KO tumors. (K) Bar plot showing the inflammatory cytokines of CD8 + T cells in MC-38 Ero1a WT and Ero1a KO tumors, assessed by scRNA-seq. Data presented as means ± SDs. ∗∗∗p < 0.001. Two-sided Student’s t test.
Anti Mouse Cd25 Pe, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd25 pe/product/Cytek Biosciences
Average 94 stars, based on 1 article reviews
anti mouse cd25 pe - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec cd25 pe miltenyi 130
ERO1A induces T cell dysfunction in response to aPD-1 treatment (A) t-distributed stochastic neighbor embedding (t-SNE) visualization of major cell clusters, colored by cell subtype. Tumors were collected after two rounds of aPD-1 treatment and processed for scRNA-seq (n = 5 mice/group). CAFs, cancer-associated fibroblasts. DCs, dendritic cells. NK, natural killer. (B) t-SNE map of major cell types in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (C) t-SNE map indicating the macrophage clusters based on the scRNA-seq data. Colored by cell subtype. (D) t-SNE map showing the sample origins of macrophages in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (E) t-SNE map depicting the M1 and M2 macrophage signatures based on the scRNA-seq data. (F) Uniform manifold approximation and projection (UMAP) plot showing the RNA velocity of CD8 + T cell subsets. RNA velocities were visualized on the UMAP of Mki67 + Tex, <t>Il2ra</t> + Texp, Tnfrsf9 + Texp, Gzmf + Tem, Ifng + Tm, Ifit1 + Tcm, and CD28 + Tm using Gaussian smoothing on a regular grid. (G and H) Diffusion map of CD8 + T cell clusters shows a resting-to-activated trajectory. The pseudotime expression changes in Lag3 , Pdcd1 , Havcr2 , and Gzmb in CD8 + T cells (G). Pseudotime trajectory of CD8 + T cell subsets in MC-38 Ero1a WT and Ero1a KO tumors (H). Colored by cell subtype. (I and J) Projection of effective CD8 + T cells (I) and proliferative CD8 + T cells (J) based on cell activation, degranulation, and proliferation levels in MC-38 Ero1a WT and Ero1a KO tumors. (K) Bar plot showing the inflammatory cytokines of CD8 + T cells in MC-38 Ero1a WT and Ero1a KO tumors, assessed by scRNA-seq. Data presented as means ± SDs. ∗∗∗p < 0.001. Two-sided Student’s t test.
Cd25 Pe Miltenyi 130, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd25 pe miltenyi 130/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd25 pe miltenyi 130 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

91
Biogems International anti mouse cd25 pe
Akk improves gut immune responses in obese mice (A) PHATE of T cells clustering in mice intestinal lymph nodes. (B–E) Percentages of CD3 + CD4 + Tregs, CD3 + CD8 + Tregs, CD4 + <t>CD25</t> + Tregs, and CD4 + CD25 + Foxp3 + Tregs. Data are expressed as mean ± SD ( n = 6), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA.
Anti Mouse Cd25 Pe, supplied by Biogems International, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd25 pe/product/Biogems International
Average 91 stars, based on 1 article reviews
anti mouse cd25 pe - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

94
Cytek Biosciences anti mouse cd25 pc61 pe cy7 tonbo
Akk improves gut immune responses in obese mice (A) PHATE of T cells clustering in mice intestinal lymph nodes. (B–E) Percentages of CD3 + CD4 + Tregs, CD3 + CD8 + Tregs, CD4 + <t>CD25</t> + Tregs, and CD4 + CD25 + Foxp3 + Tregs. Data are expressed as mean ± SD ( n = 6), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA.
Anti Mouse Cd25 Pc61 Pe Cy7 Tonbo, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd25 pc61 pe cy7 tonbo/product/Cytek Biosciences
Average 94 stars, based on 1 article reviews
anti mouse cd25 pc61 pe cy7 tonbo - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Miltenyi Biotec anti mouse cd25 reafinitytm ab
Flow cytometry analysis of tumor-infiltrating lymphocytes. To investigate effects of the combinatorial DB + FAP-IL-2v treatment on tumor-infiltrating lymphocytes, primary tumor tissue was analyzed using flow cytometry. After resection, primary tumor tissue samples were enzymatically digested to obtain a single-cell solution. To assess NK ( A ) and cytotoxic T cells ( B ) as well as Treg ( C ), the effector-cell-population-specific antigens CD335 and CD8 as well as <t>CD25</t> and FocP3 were marked, respectively. Additionally, the ratio of cytotoxic T cells to Treg ( D ) was calculated. Results are presented as a percentage of the respective effector cell population cells relative to all viable CD45- or CD3-positive leukocytes for NK and cytotoxic T cells or Treg, respectively. ANOVA followed by appropriate post-hoc comparison test and t -test. ( A ) * p < 0.05 vs. FAP-IL-2v, ( B ) * p < 0.05 vs. DB + FAP-IL-2v, ( C ) * p < 0.05 vs. DB + FAP-IL-2v, # p < 0.05 vs. FAP-IL-2v, ( D ) * p < 0.05 vs. IL-2.
Anti Mouse Cd25 Reafinitytm Ab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd25 reafinitytm ab/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
anti mouse cd25 reafinitytm ab - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

95
Miltenyi Biotec 7d4
Key antibodies for flow cytometry.
7d4, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/7d4/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
7d4 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

92
Miltenyi Biotec cd25
Key antibodies for flow cytometry.
Cd25, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd25/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
cd25 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

Image Search Results


Representative phenotypic analysis of CD25 and FoxP3 expression in CD4+ T cells of PBMC compared with LNMC. (A) Freshly isolated PBMC and LNMC were stained for CD3, CD4, CD25 and intracellular FoxP3. CD25 and FoxP3 expression was analyzed in the CD3+CD4+ population. (A) CD25+ Treg cells in PBMC and LNMC were quantified as FoxP3+ and CD25hi (MFI ≥70) as indicated in the box in the upper right quadrant. (B) Representative example of CD25+hi expression on purified CD4+ T cell subsets used in functional assays. (C) Representative example of FoxP3 expression intensity (MFI) on CD25+ CD4+ T cells in LN and PB.

Journal:

Article Title: Suppression of HIV-specific T cell activity by lymph node CD25 + regulatory T cells from HIV-infected individuals

doi: 10.1073/pnas.0611423104

Figure Lengend Snippet: Representative phenotypic analysis of CD25 and FoxP3 expression in CD4+ T cells of PBMC compared with LNMC. (A) Freshly isolated PBMC and LNMC were stained for CD3, CD4, CD25 and intracellular FoxP3. CD25 and FoxP3 expression was analyzed in the CD3+CD4+ population. (A) CD25+ Treg cells in PBMC and LNMC were quantified as FoxP3+ and CD25hi (MFI ≥70) as indicated in the box in the upper right quadrant. (B) Representative example of CD25+hi expression on purified CD4+ T cell subsets used in functional assays. (C) Representative example of FoxP3 expression intensity (MFI) on CD25+ CD4+ T cells in LN and PB.

Article Snippet: CD25 hi cells were obtained by using anti-human CD25 PE conjugated Mab (3 μl/10 6 cells) followed by a short incubation (3 min) with anti-PE immunomagnetic beads (Miltenyi, Auburn, CA).

Techniques: Expressing, Isolation, Staining, Purification, Functional Assay

The frequency and MFI of FoxP3 expression in CD4+ T cell subsets within LNMC is significantly greater than within PBMC. CD25hi (Top) and CD25− (Middle) FoxP3+ CD4+ T cell frequencies and FoxP3 MFI in CD25+ CD4+ T cells (Bottom) in parallel LNMC and PBMC isolated from 11 chronically HIV-infected individuals.

Journal:

Article Title: Suppression of HIV-specific T cell activity by lymph node CD25 + regulatory T cells from HIV-infected individuals

doi: 10.1073/pnas.0611423104

Figure Lengend Snippet: The frequency and MFI of FoxP3 expression in CD4+ T cell subsets within LNMC is significantly greater than within PBMC. CD25hi (Top) and CD25− (Middle) FoxP3+ CD4+ T cell frequencies and FoxP3 MFI in CD25+ CD4+ T cells (Bottom) in parallel LNMC and PBMC isolated from 11 chronically HIV-infected individuals.

Article Snippet: CD25 hi cells were obtained by using anti-human CD25 PE conjugated Mab (3 μl/10 6 cells) followed by a short incubation (3 min) with anti-PE immunomagnetic beads (Miltenyi, Auburn, CA).

Techniques: Expressing, Isolation, Infection

Comparison of PB and LN for the expression of surface markers used to distinguish CD25+ Treg cells and normal CD4+ T cells. LNMC and PBMC were stained for CD4, CD25, intracellular FoxP3, and either sCTLA-4, GITR, or CD127. CD25−FoxP3− and CD25hiFoxP3+ CD4+ LNMC and PBMC subsets were analyzed for expression of CD127, sCTLA-4, and GITR. P values compare LNMC and PBMC subsets. Data are of mean percent ± SD of data obtained from LNMC and PBMC isolated from 11 chronically HIV-infected individuals.

Journal:

Article Title: Suppression of HIV-specific T cell activity by lymph node CD25 + regulatory T cells from HIV-infected individuals

doi: 10.1073/pnas.0611423104

Figure Lengend Snippet: Comparison of PB and LN for the expression of surface markers used to distinguish CD25+ Treg cells and normal CD4+ T cells. LNMC and PBMC were stained for CD4, CD25, intracellular FoxP3, and either sCTLA-4, GITR, or CD127. CD25−FoxP3− and CD25hiFoxP3+ CD4+ LNMC and PBMC subsets were analyzed for expression of CD127, sCTLA-4, and GITR. P values compare LNMC and PBMC subsets. Data are of mean percent ± SD of data obtained from LNMC and PBMC isolated from 11 chronically HIV-infected individuals.

Article Snippet: CD25 hi cells were obtained by using anti-human CD25 PE conjugated Mab (3 μl/10 6 cells) followed by a short incubation (3 min) with anti-PE immunomagnetic beads (Miltenyi, Auburn, CA).

Techniques: Comparison, Expressing, Staining, Isolation, Infection

CD25+ Treg suppressive capacity assessed in HIV p24-specific proliferation assays. Total and CD25+ cell-depleted CD4+ T cells isolated from LNMC and PBMC of subjects 1–5 were stimulated with HIV p24 protein for 6 days, then pulsed with 3H thymidine 16 h. Percent suppression of proliferation by CD25+ cells was determined by comparing net cpm obtained in total versus CD25+ cell-depleted CD4+ T cell cultures (≥40% was arbitrarily considered to be a significant level of suppression). N.R., no response.

Journal:

Article Title: Suppression of HIV-specific T cell activity by lymph node CD25 + regulatory T cells from HIV-infected individuals

doi: 10.1073/pnas.0611423104

Figure Lengend Snippet: CD25+ Treg suppressive capacity assessed in HIV p24-specific proliferation assays. Total and CD25+ cell-depleted CD4+ T cells isolated from LNMC and PBMC of subjects 1–5 were stimulated with HIV p24 protein for 6 days, then pulsed with 3H thymidine 16 h. Percent suppression of proliferation by CD25+ cells was determined by comparing net cpm obtained in total versus CD25+ cell-depleted CD4+ T cell cultures (≥40% was arbitrarily considered to be a significant level of suppression). N.R., no response.

Article Snippet: CD25 hi cells were obtained by using anti-human CD25 PE conjugated Mab (3 μl/10 6 cells) followed by a short incubation (3 min) with anti-PE immunomagnetic beads (Miltenyi, Auburn, CA).

Techniques: Isolation

Representative example of CD25+ Treg suppressive capacity assessed in flow cytometry-based CTL assays by using Granzyme-B substrate cleavage as a read out. HIV Gag pre-stimulated effector unfractionated (Top plots) and CD25+ cell-depleted LNMC, alone or plus 30% CD25+CD8− MC, (Middle and Bottom Right plots, respectively) were cultured for 1 h with FL-4-labeled un-pulsed or HIV Gag peptide-pulsed autologous CD25−CD8− target cells in the presence of a Granzyme-B substrate that fluoresces when cleaved. Percent target cell killing (indicated within each plot) was defined by the frequency of substrate cleavage high events within the FL-4+ target cell gate; analyses are of FL-4+ target cells only. Substrate cleavage in target cells cultured in the absence of effector cells is shown in the Bottom Left plot.

Journal:

Article Title: Suppression of HIV-specific T cell activity by lymph node CD25 + regulatory T cells from HIV-infected individuals

doi: 10.1073/pnas.0611423104

Figure Lengend Snippet: Representative example of CD25+ Treg suppressive capacity assessed in flow cytometry-based CTL assays by using Granzyme-B substrate cleavage as a read out. HIV Gag pre-stimulated effector unfractionated (Top plots) and CD25+ cell-depleted LNMC, alone or plus 30% CD25+CD8− MC, (Middle and Bottom Right plots, respectively) were cultured for 1 h with FL-4-labeled un-pulsed or HIV Gag peptide-pulsed autologous CD25−CD8− target cells in the presence of a Granzyme-B substrate that fluoresces when cleaved. Percent target cell killing (indicated within each plot) was defined by the frequency of substrate cleavage high events within the FL-4+ target cell gate; analyses are of FL-4+ target cells only. Substrate cleavage in target cells cultured in the absence of effector cells is shown in the Bottom Left plot.

Article Snippet: CD25 hi cells were obtained by using anti-human CD25 PE conjugated Mab (3 μl/10 6 cells) followed by a short incubation (3 min) with anti-PE immunomagnetic beads (Miltenyi, Auburn, CA).

Techniques: Flow Cytometry, Cell Culture, Labeling

Comparison of PB and LN CD25+ Treg cell-mediated suppression of HIV-specific CTL activity. (A) Mean (± SD) HIV-specific CTL activity in unfractionated and CD25+ cell-depleted PBMC and LNMC. (B) Mean (± SD) percent inhibition of HIV-specific CTL activity mediated by CD25+ cells in LNMC and PBMC of patients stratified by VL (HIV RNA copies per ml). (C) Comparison of the suppressive effects of LN and PB-derived CD25hi+ CD4+ T cells on HIV-specific CTL activity. Purified CD25− or CD25hi+ CD4+ T cells were isolated from the PB and LN (subjects 3–5) and added to autologous CD25+ cell-depleted MC (at 10%) at the time of primary stimulation with HIV Gag peptides. CTL assays were performed 6 days later after exposure to HIV Gag peptide-pulsed target cells. Data are of mean (±SD) percent suppression of HIV-specific CTL activity present in control CD25+ cell-depleted MC cultured alone.

Journal:

Article Title: Suppression of HIV-specific T cell activity by lymph node CD25 + regulatory T cells from HIV-infected individuals

doi: 10.1073/pnas.0611423104

Figure Lengend Snippet: Comparison of PB and LN CD25+ Treg cell-mediated suppression of HIV-specific CTL activity. (A) Mean (± SD) HIV-specific CTL activity in unfractionated and CD25+ cell-depleted PBMC and LNMC. (B) Mean (± SD) percent inhibition of HIV-specific CTL activity mediated by CD25+ cells in LNMC and PBMC of patients stratified by VL (HIV RNA copies per ml). (C) Comparison of the suppressive effects of LN and PB-derived CD25hi+ CD4+ T cells on HIV-specific CTL activity. Purified CD25− or CD25hi+ CD4+ T cells were isolated from the PB and LN (subjects 3–5) and added to autologous CD25+ cell-depleted MC (at 10%) at the time of primary stimulation with HIV Gag peptides. CTL assays were performed 6 days later after exposure to HIV Gag peptide-pulsed target cells. Data are of mean (±SD) percent suppression of HIV-specific CTL activity present in control CD25+ cell-depleted MC cultured alone.

Article Snippet: CD25 hi cells were obtained by using anti-human CD25 PE conjugated Mab (3 μl/10 6 cells) followed by a short incubation (3 min) with anti-PE immunomagnetic beads (Miltenyi, Auburn, CA).

Techniques: Comparison, Activity Assay, Inhibition, Derivative Assay, Purification, Isolation, Control, Cell Culture

Splenocytes from DEREG mice were incubated in the absence or presence of the indicated concentrations of NAD + before staining with fluorochrome-conjugated mAbs directed against CD4 and CD25 (mAb PC61 or mAb 7D4). Gating was performed on CD4 + cells. (a) Representative dot plots of cells incubated in the absence or presence of 12 μM NAD + . (b) Percentages of CD4 + GFP + cells staining with anti-CD25 mAbs plotted as a function of the concentration of added NAD + . Results are representative of two independent experiments.

Journal: Scientific Reports

Article Title: Tuning IL-2 signaling by ADP-ribosylation of CD25

doi: 10.1038/srep08959

Figure Lengend Snippet: Splenocytes from DEREG mice were incubated in the absence or presence of the indicated concentrations of NAD + before staining with fluorochrome-conjugated mAbs directed against CD4 and CD25 (mAb PC61 or mAb 7D4). Gating was performed on CD4 + cells. (a) Representative dot plots of cells incubated in the absence or presence of 12 μM NAD + . (b) Percentages of CD4 + GFP + cells staining with anti-CD25 mAbs plotted as a function of the concentration of added NAD + . Results are representative of two independent experiments.

Article Snippet: Alternatively, after erythrocyte lysis with Ack lysis buffer (Bio Whittaker) and depletion of B-cells with Dynabead-conjugated sheep anti-mouse IgG (Invitrogen), Tregs were positively selected by magnetic cell sorting using PE conjugated anti-CD25 (7D4) and magnetic bead-conjugated anti-PE antibodies according to the manufacturer's instructions (Miltenyi Biotec).

Techniques: Incubation, Staining, Concentration Assay

ERO1A induces T cell dysfunction in response to aPD-1 treatment (A) t-distributed stochastic neighbor embedding (t-SNE) visualization of major cell clusters, colored by cell subtype. Tumors were collected after two rounds of aPD-1 treatment and processed for scRNA-seq (n = 5 mice/group). CAFs, cancer-associated fibroblasts. DCs, dendritic cells. NK, natural killer. (B) t-SNE map of major cell types in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (C) t-SNE map indicating the macrophage clusters based on the scRNA-seq data. Colored by cell subtype. (D) t-SNE map showing the sample origins of macrophages in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (E) t-SNE map depicting the M1 and M2 macrophage signatures based on the scRNA-seq data. (F) Uniform manifold approximation and projection (UMAP) plot showing the RNA velocity of CD8 + T cell subsets. RNA velocities were visualized on the UMAP of Mki67 + Tex, Il2ra + Texp, Tnfrsf9 + Texp, Gzmf + Tem, Ifng + Tm, Ifit1 + Tcm, and CD28 + Tm using Gaussian smoothing on a regular grid. (G and H) Diffusion map of CD8 + T cell clusters shows a resting-to-activated trajectory. The pseudotime expression changes in Lag3 , Pdcd1 , Havcr2 , and Gzmb in CD8 + T cells (G). Pseudotime trajectory of CD8 + T cell subsets in MC-38 Ero1a WT and Ero1a KO tumors (H). Colored by cell subtype. (I and J) Projection of effective CD8 + T cells (I) and proliferative CD8 + T cells (J) based on cell activation, degranulation, and proliferation levels in MC-38 Ero1a WT and Ero1a KO tumors. (K) Bar plot showing the inflammatory cytokines of CD8 + T cells in MC-38 Ero1a WT and Ero1a KO tumors, assessed by scRNA-seq. Data presented as means ± SDs. ∗∗∗p < 0.001. Two-sided Student’s t test.

Journal: Cell Reports Medicine

Article Title: Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity

doi: 10.1016/j.xcrm.2023.101206

Figure Lengend Snippet: ERO1A induces T cell dysfunction in response to aPD-1 treatment (A) t-distributed stochastic neighbor embedding (t-SNE) visualization of major cell clusters, colored by cell subtype. Tumors were collected after two rounds of aPD-1 treatment and processed for scRNA-seq (n = 5 mice/group). CAFs, cancer-associated fibroblasts. DCs, dendritic cells. NK, natural killer. (B) t-SNE map of major cell types in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (C) t-SNE map indicating the macrophage clusters based on the scRNA-seq data. Colored by cell subtype. (D) t-SNE map showing the sample origins of macrophages in MC-38 Ero1a WT and Ero1a KO tumors. Colored by cell subtype. (E) t-SNE map depicting the M1 and M2 macrophage signatures based on the scRNA-seq data. (F) Uniform manifold approximation and projection (UMAP) plot showing the RNA velocity of CD8 + T cell subsets. RNA velocities were visualized on the UMAP of Mki67 + Tex, Il2ra + Texp, Tnfrsf9 + Texp, Gzmf + Tem, Ifng + Tm, Ifit1 + Tcm, and CD28 + Tm using Gaussian smoothing on a regular grid. (G and H) Diffusion map of CD8 + T cell clusters shows a resting-to-activated trajectory. The pseudotime expression changes in Lag3 , Pdcd1 , Havcr2 , and Gzmb in CD8 + T cells (G). Pseudotime trajectory of CD8 + T cell subsets in MC-38 Ero1a WT and Ero1a KO tumors (H). Colored by cell subtype. (I and J) Projection of effective CD8 + T cells (I) and proliferative CD8 + T cells (J) based on cell activation, degranulation, and proliferation levels in MC-38 Ero1a WT and Ero1a KO tumors. (K) Bar plot showing the inflammatory cytokines of CD8 + T cells in MC-38 Ero1a WT and Ero1a KO tumors, assessed by scRNA-seq. Data presented as means ± SDs. ∗∗∗p < 0.001. Two-sided Student’s t test.

Article Snippet: Anti-mouse CD25 PE , Tonbo , Cat# 50-0251; RRID: AB_2621757.

Techniques: Diffusion-based Assay, Expressing, Activation Assay

Journal: Cell Reports Medicine

Article Title: Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity

doi: 10.1016/j.xcrm.2023.101206

Figure Lengend Snippet:

Article Snippet: Anti-mouse CD25 PE , Tonbo , Cat# 50-0251; RRID: AB_2621757.

Techniques: Control, Purification, Virus, Recombinant, CCK-8 Assay, Transfection, Protease Inhibitor, SYBR Green Assay, Saline, Lysis, Multiplex Assay, Cytotoxicity Assay, Cell Isolation, Enzyme-linked Immunosorbent Assay, Bicinchoninic Acid Protein Assay, Software

Akk improves gut immune responses in obese mice (A) PHATE of T cells clustering in mice intestinal lymph nodes. (B–E) Percentages of CD3 + CD4 + Tregs, CD3 + CD8 + Tregs, CD4 + CD25 + Tregs, and CD4 + CD25 + Foxp3 + Tregs. Data are expressed as mean ± SD ( n = 6), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA.

Journal: iScience

Article Title: Akkermansia muciniphila ameliorates fatty liver through microbiota-derived α-ketoisovaleric acid metabolism and hepatic PI3K/Akt signaling

doi: 10.1016/j.isci.2025.112458

Figure Lengend Snippet: Akk improves gut immune responses in obese mice (A) PHATE of T cells clustering in mice intestinal lymph nodes. (B–E) Percentages of CD3 + CD4 + Tregs, CD3 + CD8 + Tregs, CD4 + CD25 + Tregs, and CD4 + CD25 + Foxp3 + Tregs. Data are expressed as mean ± SD ( n = 6), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA.

Article Snippet: Anti-Mouse CD25 + PE , BioGems , Cat# 07312-60.

Techniques:

Gut fungi is the key in Akk improving gut immune responses in organoids (A) Co-culture of colonic organoids, fecal microbiota and Akk. (B) Fluorescent images of colonic organoids with DAPI-labeled cells, and number of organoid crypts. Scale bars: 100 μm. (C) Relative abundance of fungal in co-culture system. (D) Percentages of CD3 + CD4 + , CD3 + CD8 + , CD4 + CD25 + , and CD4 + CD25 + Foxp3 + Tregs in organoids. (E) Relative content of metabolites in co-culture system. (F) Co-culture of colonic organoids, fluconazole, fecal microbiota and Akk. (G) Fluorescent images of colonic organoids with DAPI-labeled cells, and number of organoid crypts. Scale bars: 50 μm. (H) Percentages of CD3 + CD4 + , CD3 + CD8 + , CD4 + CD25 + , and CD4 + CD25 + Foxp3 + Tregs in organoids. (I and J) Relative content of metabolites (α-ketoisovaleric acid and glycylleucine) in co-culture system. <xref ref-type=Figures 7 A–7E and Figures 7 F–7J represent experiments from different batches, respectively. Data are expressed as mean ± SD (n = 6–8), ns p >0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA. " width="100%" height="100%">

Journal: iScience

Article Title: Akkermansia muciniphila ameliorates fatty liver through microbiota-derived α-ketoisovaleric acid metabolism and hepatic PI3K/Akt signaling

doi: 10.1016/j.isci.2025.112458

Figure Lengend Snippet: Gut fungi is the key in Akk improving gut immune responses in organoids (A) Co-culture of colonic organoids, fecal microbiota and Akk. (B) Fluorescent images of colonic organoids with DAPI-labeled cells, and number of organoid crypts. Scale bars: 100 μm. (C) Relative abundance of fungal in co-culture system. (D) Percentages of CD3 + CD4 + , CD3 + CD8 + , CD4 + CD25 + , and CD4 + CD25 + Foxp3 + Tregs in organoids. (E) Relative content of metabolites in co-culture system. (F) Co-culture of colonic organoids, fluconazole, fecal microbiota and Akk. (G) Fluorescent images of colonic organoids with DAPI-labeled cells, and number of organoid crypts. Scale bars: 50 μm. (H) Percentages of CD3 + CD4 + , CD3 + CD8 + , CD4 + CD25 + , and CD4 + CD25 + Foxp3 + Tregs in organoids. (I and J) Relative content of metabolites (α-ketoisovaleric acid and glycylleucine) in co-culture system. Figures 7 A–7E and Figures 7 F–7J represent experiments from different batches, respectively. Data are expressed as mean ± SD (n = 6–8), ns p >0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, compared with the Mod group, and p value was calculated using Dunnet’s post hoc test in one-way ANOVA.

Article Snippet: Anti-Mouse CD25 + PE , BioGems , Cat# 07312-60.

Techniques: Co-Culture Assay, Labeling

Flow cytometry analysis of tumor-infiltrating lymphocytes. To investigate effects of the combinatorial DB + FAP-IL-2v treatment on tumor-infiltrating lymphocytes, primary tumor tissue was analyzed using flow cytometry. After resection, primary tumor tissue samples were enzymatically digested to obtain a single-cell solution. To assess NK ( A ) and cytotoxic T cells ( B ) as well as Treg ( C ), the effector-cell-population-specific antigens CD335 and CD8 as well as CD25 and FocP3 were marked, respectively. Additionally, the ratio of cytotoxic T cells to Treg ( D ) was calculated. Results are presented as a percentage of the respective effector cell population cells relative to all viable CD45- or CD3-positive leukocytes for NK and cytotoxic T cells or Treg, respectively. ANOVA followed by appropriate post-hoc comparison test and t -test. ( A ) * p < 0.05 vs. FAP-IL-2v, ( B ) * p < 0.05 vs. DB + FAP-IL-2v, ( C ) * p < 0.05 vs. DB + FAP-IL-2v, # p < 0.05 vs. FAP-IL-2v, ( D ) * p < 0.05 vs. IL-2.

Journal: Cancers

Article Title: The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD 2 Antibody Dinutuximab Beta

doi: 10.3390/cancers14194842

Figure Lengend Snippet: Flow cytometry analysis of tumor-infiltrating lymphocytes. To investigate effects of the combinatorial DB + FAP-IL-2v treatment on tumor-infiltrating lymphocytes, primary tumor tissue was analyzed using flow cytometry. After resection, primary tumor tissue samples were enzymatically digested to obtain a single-cell solution. To assess NK ( A ) and cytotoxic T cells ( B ) as well as Treg ( C ), the effector-cell-population-specific antigens CD335 and CD8 as well as CD25 and FocP3 were marked, respectively. Additionally, the ratio of cytotoxic T cells to Treg ( D ) was calculated. Results are presented as a percentage of the respective effector cell population cells relative to all viable CD45- or CD3-positive leukocytes for NK and cytotoxic T cells or Treg, respectively. ANOVA followed by appropriate post-hoc comparison test and t -test. ( A ) * p < 0.05 vs. FAP-IL-2v, ( B ) * p < 0.05 vs. DB + FAP-IL-2v, ( C ) * p < 0.05 vs. DB + FAP-IL-2v, # p < 0.05 vs. FAP-IL-2v, ( D ) * p < 0.05 vs. IL-2.

Article Snippet: For detection of different tumor-infiltrating leukocyte populations described below, the following Ab were utilized: APC-Vio ® 770-labeled anti-mouse CD3 REAfinityTM Ab, VioGreenTM-labeled anti-mouse CD4 Antibody REAfinityTM, PerCP-labeled anti-mouse CD8a REAfinityTM Ab, Vio ® Bright FITC-labeled anti-mouse CD11b REAfinityTM Ab, PE-Vio ® 770-labeled anti-mouse CD25 REAfinityTM Ab, PE-labeled anti-mouse CD335 REAfinityTM Ab, APC-labeled anti-mouse FoxP3 REAfinityTM Ab (all Miltenyi Biotec, Teterow, Germany), APC/Cy-7-labeled anti-mouse Ly6C Ab and PerCP-labeled anti-mouse Ly6G Ab (BioLegend, San Diego, CA, USA).

Techniques: Flow Cytometry, Comparison

Key antibodies for flow cytometry.

Journal: Gut Microbes

Article Title: Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

doi: 10.1080/19490976.2023.2247053

Figure Lengend Snippet: Key antibodies for flow cytometry.

Article Snippet: anti-CD25 (RRID:AB_2784091, PE-VIO770, clone 7D4) , Miltenyi.

Techniques: Cytometry, Staining